Showing results (841-850 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|September 22, 2010
The impact of the Orphan Drug Act on the development and advancement of neurological products for rare diseases: a descriptive reviewK A Burke, S N Freeman, M A Imoisili, et al.Clinical Pharmacology and Therapeutics|September 22, 2010
PMDA's challenge to accelerate clinical development and review of new drugs in JapanK Ichimaru, S Toyoshima, Y UyamaClinical Pharmacology and Therapeutics|September 22, 2010
Neuroenhancement: wisdom of the masses or "false phronesis"?D Larriviere, M A WilliamsClinical Pharmacology and Therapeutics|September 22, 2010
Efficacy, safety, and ethics of cosmetic neurology far from settledK Flower, L Li, C-Y A Chen, et al.Clinical Pharmacology and Therapeutics|November 19, 2010
Developing treatments for female sexual dysfunctionR Jordan, T J Hallam, P Molinoff, et al.Clinical Pharmacology and Therapeutics|November 19, 2010
Dapoxetine for premature ejaculationA M Feige, M R Pinsky, W J G HellstromClinical Pharmacology and Therapeutics|December 24, 2010
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS studyL A Donnelly, A S F Doney, R Tavendale, et al.Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.Clinical Pharmacology and Therapeutics|April 8, 2011
Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactionsO Zolk, M F FrommClinical Pharmacology and Therapeutics|April 1, 2011
Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare dataS Setoguchi, W H Shrank, J Liu, et al.Pageof 941